Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Closone (HK inno.N Corporation)
- Development stage
- Unknown
- Lead developer
- HK inno.N Corporation
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**Closone** is an oral fixed-dose antiplatelet combination of clopidogrel bisulfate and aspirin developed and manufactured by HK inno.N for prevention of atherothrombotic events in patients with coronary artery disease, including after percutaneous coronary intervention. Clopidogrel is a prodrug whose active metabolite irreversibly inhibits the platelet P2Y12 ADP receptor, while aspirin irreversibly inhibits platelet cyclooxygenase and suppresses thromboxane A2 production; together, these complementary mechanisms reduce platelet activation and aggregation. HK inno.N lists Closone as a prescription fixed-dose combination for atherosclerosis and thromboembolism, and Phase 4 studies evaluated its non-inferiority versus separately administered clopidogrel and aspirin after PCI. ([inno-n.com](https://www.inno-n.com/eng/business/medicine/view?bpc_cd=P102&no=301))
- Brand names
- Closone
- Other names
- aspirin + clopidogrelclopidogrel + aspirinclopidogrel bisulfate + aspirin
02
Targets
PGHS-1 (Prostaglandin G/H Synthase 1)P2Y (P2Y receptors)
Beyond the preview
Go deeper on Closone (HK inno.N Corporation).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Closone (HK inno.N Corporation).